Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work? https://lnkd.in/gKwvmDSW First published on Eli Lilly and Pfizer have both recently launched direct-to-consumer platforms allowing patients to bypass an in-person doctor visit or brick-and-mortar pharmacy. Their decisions suggest large pharmaceutical companies are exploring new ways to [...]
Pennsylvania NY NJ Biotech Networks’ Post
More Relevant Posts
-
Highmark Health names Buffalo exec to lead provider-partnership strategy https://lnkd.in/gAnipyhd Highmark Health named Dr. Michael Edbauer, its market president for its New York operations, to a new post and named a veteran BlueCross BlueShield executive to replace him in New York. Click here to view [...]
Highmark Health names Buffalo exec to lead provider-partnership strategy
https://pnbn.org
-
Health systems applaud Pennsylvania’s new law to expand telemedicine access https://lnkd.in/gauZvZhM The bill’s sponsor, state Sen. Elder Vogel, said the effort was 10 years in the making. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Health systems applaud Pennsylvania’s new law to expand telemedicine access
https://pnbn.org
-
Intellia to respond to lawsuit over in vivo therapy patents https://lnkd.in/gRvY_gZZ Intellia Therapeutics said it will respond to a lawsuit filed Monday in a Delaware federal court alleging it infringed on several of BlueAllele’s patents covering methods for targeted insertion of DNA into genes. Intellia has [...]
Intellia to respond to lawsuit over in vivo therapy patents
https://pnbn.org
-
12 Philadelphia-area health care organizations picked for new dementia care payment model https://lnkd.in/gKerf4f3 As part of the program, the Centers for Medicare and Medicaid Services will provide up to $2,500 per year for respite services to enable dementia patient caregivers to take temporary breaks from their caregiving responsibilities. [...]
12 Philadelphia-area health care organizations picked for new dementia care payment model
https://pnbn.org
-
Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows https://lnkd.in/gmPmFZdW A meta-analysis of CAR-T cell therapy studies found that just over half of cancer patient deaths that are not because of relapse are due to infections. “The main takeaway as clinicians is infections, infections, infections,” [...]
Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows
https://pnbn.org
-
Roche stops pivotal TIGIT trial after Keytruda lands knockout blow at first attempt https://lnkd.in/gbzq-YtZ Keytruda has beaten Roche’s TIGIT drug candidate at the first interim analysis of a phase 2/3 lung cancer trial, prompting the Swiss drugmaker to stop the study and consider changes to the broader program. The [...]
Roche stops pivotal TIGIT trial after Keytruda lands knockout blow at first attempt
https://pnbn.org
-
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing https://lnkd.in/gTkJQMez Published: Jul 08, 2024 By Tyler Patchen Pictured: Hundred dollar bill with upward graph/iStock, Darren415 Myricx Bio announced Monday that it has netted a £90 million ($115.5 million) Series A investment round to… Click here to [...]
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing
https://pnbn.org
-
Highmark Western and Northeastern New York names new president https://lnkd.in/ggHjfajQ The shuffle comes three years after the company affiliated with Highmark Inc. in Pennsylvania. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Highmark Western and Northeastern New York names new president
https://pnbn.org
-
‘Galvanized’ by early data, British biotech Myricx secures $114M series A to take ADCs into clinic https://lnkd.in/g59bQHbe When it comes to the red-hot antibody-drug conjugate (ADC) space, Big Pharmas have tended to head to China to build up their pipelines. But U.K.-based Myricx Bio has caught the eye of a crop of [...]
‘Galvanized’ by early data, British biotech Myricx secures $114M series A to take ADCs into clinic
https://pnbn.org
-
Eli Lilly’s Alzheimer’s OK; GSK picks its mRNA bets; Megaround tally; Biosecure’s shadow; and more https://lnkd.in/gDNjg6wk Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up [...]
Eli Lilly’s Alzheimer’s OK; GSK picks its mRNA bets; Megaround tally; Biosecure’s shadow; and more
https://pnbn.org
